Microbiology Study Guide: Disease, Immunology, and Antimicrobial Drugs

Disease, Pathogenicity, and Epidemiology

Resident Flora (Normal Flora)

The resident flora refers to the population of microorganisms that normally inhabit various parts of the human body without causing disease under normal circumstances.

• Definition: Resident flora are the microbes that colonize the body and are usually beneficial or harmless.

• Locations: Commonly found on the skin, oral cavity, gastrointestinal tract, upper respiratory tract, and urogenital tract.

• Absent Areas: Internal organs (e.g., heart, liver, kidneys), blood, cerebrospinal fluid, and lower respiratory tract typically do not have resident flora due to protective barriers.

• Clinical Importance: Knowledge of resident flora helps clinical microbiologists distinguish between normal and pathogenic microbes, aiding in diagnosis and treatment.

Benefits of Normal Flora

Normal flora play a crucial role in maintaining health and preventing disease.

• Competitive Exclusion: They compete with pathogens for nutrients and space, reducing the risk of infection.

• Immune Stimulation: Stimulate the immune system to remain active and responsive.

• Production of Essential Compounds: Some produce vitamins (e.g., vitamin K in the gut).

Pathogen Entry and Disease Causation

Pathogens must overcome several barriers to cause disease in a host.

• Portal of Entry: Pathogens enter the body through specific sites (e.g., skin breaks, respiratory tract, gastrointestinal tract).

• Colonization: Must adhere to host tissues and multiply.

• Invasion and Evasion: Must evade host defenses and invade tissues.

• Damage: Cause actual disease by damaging host cells or tissues.

• Example: Streptococcus pyogenes enters via the throat, adheres, evades immune response, and causes strep throat.

Virulence Factors

Virulence factors are molecules produced by pathogens that enhance their ability to cause disease.

• Definition: Traits that enable a microbe to invade and damage host tissues.

• Examples:

  • Toxins: e.g., botulinum toxin from Clostridium botulinum

  • Adhesins: e.g., fimbriae in Escherichia coli

  • Capsules: e.g., polysaccharide capsule in Streptococcus pneumoniae

Endotoxins vs. Exotoxins

Endotoxins and exotoxins are two major classes of bacterial toxins.

• Endotoxins: Components of the outer membrane of Gram-negative bacteria (lipopolysaccharide, LPS). Released upon cell death. Cause fever and shock.

• Exotoxins: Proteins secreted by both Gram-positive and Gram-negative bacteria. Highly specific and potent (e.g., tetanus toxin).

• Comparison Table:

Feature	Endotoxin	Exotoxin
Chemical Nature	LPS (lipid + polysaccharide)	Protein
Source	Gram-negative bacteria	Gram-positive & Gram-negative bacteria
Toxicity	Low to moderate	High
Heat Stability	Stable	Unstable
Effect on Host	Fever, shock	Specific tissue damage

Stages of Infection

Infectious diseases progress through distinct stages.

• Incubation Period: Time between entry and appearance of symptoms.

• Prodromal Stage: Early, mild symptoms.

• Acute Stage: Peak of symptoms and pathogen multiplication.

• Convalescence: Recovery and decline of symptoms.

Reservoirs vs. Transmission

A reservoir is the natural habitat of a pathogen; transmission is the process by which it spreads.

• Reservoirs: Humans, animals, environment (e.g., water, soil).

• Transmission: Direct contact, airborne, vector-borne, etc.

• Example: Salmonella reservoir is poultry; transmission is via contaminated food.

Biological vs. Mechanical Vectors

Vectors are organisms that transmit pathogens between hosts.

• Biological Vector: Pathogen develops or multiplies within the vector (e.g., mosquito for malaria).

• Mechanical Vector: Vector physically carries pathogen without development (e.g., housefly on food).

Public Health and Epidemiology

Public health laboratories and agencies track and prevent infectious diseases.

• CDC: Centers for Disease Control and Prevention monitors disease trends, outbreaks, and provides guidelines.

• Key Terms:

  • Morbidity Rate: Number of cases of disease in a population.

  • Mortality Rate: Number of deaths due to disease.

  • Case Reporting: Systematic documentation of disease cases.

  • Pandemic: Worldwide epidemic.

  • Epidemic: Sudden increase in cases in a region.

  • Endemic: Constant presence of disease in a population.

Immunology

Primary Barriers (First Line of Defense)

The first line of defense consists of physical and chemical barriers that prevent pathogen entry.

• Skin: Acts as a physical barrier.

• Mucous Membranes: Trap and expel microbes.

• Chemical Barriers: Lysozyme in tears, acidic pH in stomach.

Non-Specific vs. Specific Immune Response

The immune system has two major components: non-specific (innate) and specific (adaptive) responses.

• Non-Specific (Second Line): Includes phagocytes, inflammation, fever, complement system.

• Specific (Third Line): Involves lymphocytes (B cells and T cells), antibodies, and memory cells.

• Example: Phagocytosis (innate) vs. antibody production (adaptive).

Complement System Activation

The complement system can be activated by different pathways, leading to pathogen destruction.

• Classical Pathway: Triggered by antibodies bound to antigens.

• Alternative Pathway: Activated directly by pathogen surfaces.

• Results: Opsonization, inflammation, and cell lysis.

Humoral vs. Cell-Mediated Immunity

These are two branches of the adaptive immune system.

• Humoral Immunity: Mediated by B cells and antibodies; targets extracellular pathogens.

• Cell-Mediated Immunity: Mediated by T cells; targets intracellular pathogens (e.g., viruses).

Clonal Selection

Clonal selection is the process by which specific lymphocytes are activated and proliferate in response to an antigen.

• Activation: Antigen binds to a specific lymphocyte receptor.

• Result: Production of clones that target the antigen.

Antibodies (Immunoglobulins)

Antibodies are proteins produced by B cells that bind to specific antigens.

• Structure: Y-shaped molecules with variable regions for antigen binding.

• Function: Neutralize pathogens, opsonize for phagocytosis, activate complement.

• Types: IgG, IgM, IgA, IgE, IgD.

Vaccines and Immunoglobulins

Vaccines stimulate immunity; immunoglobulins can be used therapeutically.

• Vaccines: Induce active immunity by exposing the immune system to antigens.

• Immunoglobulin (Antitoxin): Passive immunity; used to neutralize toxins.

Direct vs. Indirect Tests

Laboratory tests can detect pathogens or antibodies.

• Direct Tests: Detect the pathogen itself (e.g., antigen detection).

• Indirect Tests: Detect antibodies produced in response to infection.

ELISA, FAT, and Agglutination Tests

These are common immunological assays used in diagnostics.

• ELISA (Enzyme-Linked Immunosorbent Assay): Detects antigens or antibodies using enzyme-linked reactions.

• FAT (Fluorescent Antibody Test): Uses fluorescent-labeled antibodies to detect antigens.

• Agglutination Tests: Detect antibodies or antigens by visible clumping.

Specimen Collection and Handling

Proper specimen collection, handling, and transport are essential for accurate laboratory diagnosis.

• Collection: Use sterile techniques to avoid contamination.

• Handling: Maintain appropriate temperature and conditions.

• Transport: Use suitable containers and timely delivery to the lab.

Antimicrobial Drugs

Laboratory Information for Physicians

Laboratories provide information beyond pathogen identification, such as drug susceptibility and resistance patterns.

• Susceptibility Testing: Determines which antibiotics are effective.

• Resistance Mechanisms: Identifies resistance genes or traits.

Minimum Inhibitory Concentration (MIC)

MIC is the lowest concentration of an antimicrobial that inhibits visible growth of a microorganism.

• Determination: Serial dilution method; observe growth inhibition.

• Equation:

$MIC = \text{Lowest concentration with no visible growth}$

Narrow vs. Broad Spectrum Antibiotics

Antibiotics are classified based on the range of organisms they affect.

• Narrow Spectrum: Effective against specific groups (e.g., penicillin for Gram-positive bacteria).

• Broad Spectrum: Effective against a wide range (e.g., tetracycline for Gram-positive and Gram-negative).

• Preference: Narrow spectrum preferred to minimize disruption of normal flora and resistance development.

Choosing Antibiotics: Key Considerations

• Pathogen Identity

• Drug Susceptibility

• Patient Factors: Allergies, age, pregnancy, organ function

• Drug Pharmacokinetics: Absorption, distribution, metabolism, excretion

Prokaryotic vs. Eukaryotic Cells: Drug Targets

Antibiotics exploit differences between prokaryotic and eukaryotic cells.

• Cell Wall: Present in bacteria, absent in humans.

• Ribosomes: 70S in bacteria, 80S in humans.

• Metabolic Pathways: Unique bacterial enzymes.

Antifungal and Antiviral Drug Challenges

Developing non-toxic drugs for fungal and viral infections is difficult due to similarities with host cells and viral reliance on host machinery.

• Antifungal Drugs: Fungi are eukaryotic, so fewer unique targets.

• Antiviral Drugs: Viruses use host cell machinery, making selective targeting challenging.

• Antibiotics: Ineffective against viruses due to lack of bacterial structures.

Additional info: These study notes expand on the question prompts by providing definitions, examples, and context for key microbiology concepts relevant to college-level coursework.